✦ LIBER ✦

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®

✍ Scribed by Scott Kitchener

Book ID: 116957200
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 44 KB
Volume: 22
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2004.01.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis and death following vaccinatio

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

✍ Raymond C Chan; David J Penney; Dianne Little; Ian W Carter; Jason A Roberts; Wi 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 56 KB

Heterogeneous nature of the genome of th

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

✍ Konstantin V Pugachev; Simeon W Ocran; Farshad Guirakhoo; Dean Furby; Thomas P M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Neutralizing antibody response to booste

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine

✍ M.J. Hepburn; M.G. Kortepeter; P.R. Pittman; E.F. Boudreau; J.A. Mangiafico; P.A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Further observations on 17D-yellow fever

Further observations on 17D-yellow fever vaccination by scarification, with and without simultaneous smallpox vaccination

✍ Captain P.D. Meers 📂 Article 📅 1960 🏛 Elsevier Science 🌐 English ⚖ 623 KB

Neurologic disease associated with 17D-2

Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

✍ Ann W. McMahon; Rachel B. Eidex; Anthony A. Marfin; Michelle Russell; James J. S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Human antibody response to immunization

Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine

✍ M. Kayser; H. Klein; I. Paasch; J. Pilaski; H. Blenk; K. Heeg 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

The antibody response against flaviviruses tick-borne encephalitis (TBE), Kyasanur Forest disease (KFD), Murray Valley encephalitis (MVE), West Nile fever (WNF), Japanese B encephalitis (JE), dengue 2 (DEN-2), and yellow fever (YF) was studied in humans after administration of an inactivated TBE vir